Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
09. Dezember 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
04. Dezember 2024 16:15 ET
|
OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
12. November 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
06. November 2024 16:45 ET
|
OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Head and Neck Cancer Diagnostics Market Research Report 2023-2030: Increasing Focus on Personalized Medicine, Targeted Therapies, Liquid Biopsy and Molecular Testing Expands Opportunities
04. November 2024 11:16 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
08. Oktober 2024 08:30 ET
|
OncoCyte Corporation
Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO...
Oncocyte Signs Leading Transplant Centers in US and Germany
02. Oktober 2024 18:41 ET
|
OncoCyte Corporation
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in clinical product development process and has...
Growth Opportunities in the Tissue Diagnostics Industry 2024-2029: Multiomics Analysis for Precision Diagnostics, Comprehensive Diagnostic Panels for Early Identification of Cancer Biomarkers
02. Oktober 2024 07:04 ET
|
Research and Markets
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global...
Precision Diagnostics Market Size Expected to Reach USD 224.53 Billion by 2032 with a CAGR of 13.50% - SNS Insider
24. September 2024 09:00 ET
|
SNS Insider pvt ltd
Pune, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Diagnostics Market Size & Growth Analysis: The Precision Diagnostics Market size was valued at USD 75.87 billion in 2023 and is projected to...
Preeclampsia Diagnostics Market Projected to Reach $1.211 Billion by 2029: Efforts to Boost Awareness and Diagnostic Accessibility Boosts Expansion
16. August 2024 07:20 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Preeclampsia Diagnostics Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The prevalence of...